Pharmaceutical Packaging Market Outlook:
Pharmaceutical Packaging Market size was over USD 150.7 billion in 2025 and is projected to reach USD 447.57 billion by 2035, growing at around 11.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of pharmaceutical packaging is evaluated at USD 166.3 billion.
This can be attributed to the growing health concerns and the increased use of medicines worldwide. Further there has been rise in adoption of generic drugs which is also estimated to boost the growth of the market over the forecast period. Currently, 90% (9 out of 10) of all prescriptions written in the United States are for generic medications. Since it is necessary to pack and safeguard medications during storage and transportation, this packaging plays a significant part in the manufacturing of generic medications. Consequently, the use of pharmaceutical packaging would increase as the demand for generic medications rises.
Additionally, the manufacturing of novel drugs is also estimated to drive the market growth. The novel medicine packaging method has prefilled inhalers and syringes, which are single-dose vaccination units. The prefilled inhalers and syringes are made to prevent the packed medications from coming into direct touch with the patient or the environment, preventing contamination. By allowing for a self-administered metered dosage, it also decreases waste and increases patient compliance. Also, large number of pharmaceutical companies are shifting towards sustainable packaging owing to the growing concern for environment. They are extensively using recyclable materials and biodegradable packaging for packaging. One of the most extensively used material is polyethylene terephthalate by pharmaceutical companies. Hence owing to the rising adoption of sustainable packaging the market is estimated to boost further.
